- Home
- CLMB vs ORKA Comparison
CLMB vs ORKA Comparison
Compare CLMB & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMB
- ORKA
- Stock Information
- Founded
- CLMB 1982
- ORKA 2004
- Country
- CLMB United States
- ORKA United States
- Employees
- CLMB N/A
- ORKA N/A
- Industry
- CLMB Retail: Computer Software & Peripheral Equipment
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CLMB Technology
- ORKA Health Care
- Exchange
- CLMB Nasdaq
- ORKA Nasdaq
- Market Cap
- CLMB 622.6M
- ORKA 580.3M
- IPO Year
- CLMB N/A
- ORKA N/A
- Fundamental
- Price
- CLMB $137.20
- ORKA $20.43
- Analyst Decision
- CLMB Buy
- ORKA Strong Buy
- Analyst Count
- CLMB 1
- ORKA 7
- Target Price
- CLMB $136.00
- ORKA $43.00
- AVG Volume (30 Days)
- CLMB 48.3K
- ORKA 520.4K
- Earning Date
- CLMB 10-29-2025
- ORKA 11-12-2025
- Dividend Yield
- CLMB 0.50%
- ORKA N/A
- EPS Growth
- CLMB 59.50
- ORKA N/A
- EPS
- CLMB 4.81
- ORKA N/A
- Revenue
- CLMB $578,437,000.00
- ORKA N/A
- Revenue This Year
- CLMB $28.14
- ORKA N/A
- Revenue Next Year
- CLMB $5.89
- ORKA N/A
- P/E Ratio
- CLMB $28.45
- ORKA N/A
- Revenue Growth
- CLMB 56.44
- ORKA N/A
- 52 Week Low
- CLMB $88.90
- ORKA $5.49
- 52 Week High
- CLMB $145.02
- ORKA $31.13
- Technical
- Relative Strength Index (RSI)
- CLMB 56.23
- ORKA 68.72
- Support Level
- CLMB $131.78
- ORKA $18.19
- Resistance Level
- CLMB $145.00
- ORKA $21.18
- Average True Range (ATR)
- CLMB 4.31
- ORKA 1.42
- MACD
- CLMB -0.18
- ORKA 0.41
- Stochastic Oscillator
- CLMB 45.05
- ORKA 89.03
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.